Skip to main content
. Author manuscript; available in PMC: 2022 Dec 13.
Published in final edited form as: Leuk Lymphoma. 2015 May 12;57(1):34–38. doi: 10.3109/10428194.2015.1040012

Figure 1.

Figure 1.

(A) Overall survival for patients treated with ≤ 12 Gy (red line) and > 12 Gy (blue line); p = 0.63. (B) Progression-free survival for lesions treated with ≤ 12 Gy (red line) and > 12 Gy (blue line); p = 0.32.